Associations between CLIP and sarcopenia are observed quite consistently and underlying
mechanisms become apparent. Exercise remains the mainstay intervention to lower CLIP …

Sarcopenia is the loss of skeletal muscle mass and function with aging. Although the term
sarcopenia was first coined in 1989, its etiology is still poorly understood. Moreover, a …

Background Chronic low‐grade inflammation has been suggested as one of the key
elements in the development of sarcopenia, but in contrast to disease‐related loss of muscle …

The development of sarcopenia is a complex multi-factorial process which begins in mid-life
and accelerates after the age of 75 years. Although exercise, nutritional supplementation …

Sarcopenia is an age-associated decline of skeletal muscle mass and function and is known
to lead to frailty, cachexia, osteoporosis, metabolic syndromes, and death. Notwithstanding …

Sarcopenia is the degenerative loss of skeletal muscle that occurs naturally in individuals as
they age. Although many factors underlie sarcopenia, epidemio-logical and experimental …

Background Ageing, chronic diseases, prolonged inactivity, and inadequate nutrition pose a
severe threat to skeletal muscle health and function. To date, experimental evidence …

Aging is associated with inflammatory chronic conditions such as obesity, cardiovascular
disease, insulin resistance, and arthritis. Sarcopenia—muscle loss with aging—is …

Efforts to develop a consensus definition are ongoing and will greatly facilitate the
development and testing of novel interventions for sarcopenia. Although pharmaceutical …

Background Sarcopenia is a progressive age‐related skeletal muscle disorder associated
with increased likelihood of adverse outcomes. Muscle wasting is often accompanied by an …